Back to homepage

Tag "Serum Institute of India"

5 killed in Serum Institute plant fire, Covid vaccine safe

5 killed in Serum Institute plant fire, Covid vaccine safe

🕔19:22, 21.Jan 2021

Pune, Jan 21  At least five persons suffocated to death as a major fire broke out in an under-construction building in a plant of global vaccine giant, the Serum Institute of India (SII), here on Thursday afternoon, shocking the country.

Read Full Article
Yet to receive licence to export Covishield: SII

Yet to receive licence to export Covishield: SII

🕔15:00, 4.Jan 2021

New Delhi, Jan 4  The Serum Institute of India (SII) clarified on Monday that the company is yet to receive the permission from the authority here to export its Covid-19 vaccine to other nations, the company official told IANS. The

Read Full Article
SII expects nod for Covid-19 vaccine in ‘few days’

SII expects nod for Covid-19 vaccine in ‘few days’

🕔06:57, 29.Dec 2020

New Delhi, Dec 29  Pune-based Serum Institute of India on Monday expressed hope at the possibility of Covid-19 vaccine – Covishield receiving the regulatory approval in “few days”, while emphasising that the company has a massive stockpile 40-50 million doses.

Read Full Article
SII seeks emergency use nod for Covishield

SII seeks emergency use nod for Covishield

🕔13:27, 7.Dec 2020

New Delhi, Dec 7  , (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine,

Read Full Article
Vaccine will not be released for mass use unless proven immunogenic: Serum Institute

Vaccine will not be released for mass use unless proven immunogenic: Serum Institute

🕔15:57, 1.Dec 2020

Chennai, Dec 1  Vaccine development company Serum Institute, India on Tuesday said the Covidshield vaccine will not be released for mass use unless it is proven immunogenic, and safe. The company also said the serious adverse event (SAE) that happened

Read Full Article
Probably by 2024, every Indian will get vaccinated: SII

Probably by 2024, every Indian will get vaccinated: SII

🕔14:35, 20.Nov 2020

New Delhi, Nov 20 Serum Institute of India (SII) CEO Adar Poonawalla has said that every Indian will get vaccinated for Covid 19 probably by 2024. Speaking at a media event, Poonawalla said the Oxford AstraZeneca Covid-19 vaccine should be available

Read Full Article
SII aims to have 100m doses of AstraZeneca vaccine ready by Dec

SII aims to have 100m doses of AstraZeneca vaccine ready by Dec

🕔07:09, 14.Nov 2020

New Delhi, Nov 14  Serum Institute of India (SII) is ramping up production of AstraZeneca’s Covid-19 vaccine, aiming to have 100 million doses ready by December for a vaccination drive that could begin across India that same month, Bloomberg reported.

Read Full Article
India will have ‘approved’ vaccine by 2021 Q1: Bernstein Research

India will have ‘approved’ vaccine by 2021 Q1: Bernstein Research

🕔11:55, 28.Aug 2020

New York, Aug 28  India is on course to have an “approved” vaccine within the first quarter of calendar year 2021 and Pune based Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, is well placed to

Read Full Article
Covishield will be commercialised once trials are successful: SII

Covishield will be commercialised once trials are successful: SII

🕔07:49, 24.Aug 2020

New Delhi, Aug 24  Serum Institute of India, has clarified that the current claims surrounding Covishield’s availability in the media are completely false and conjectural. “Presently, the government has granted us permission to only manufacture the vaccine and stockpile it

Read Full Article
Serum Institute to price Covid vaccine at less than Rs 250/dose

Serum Institute to price Covid vaccine at less than Rs 250/dose

🕔18:05, 7.Aug 2020

New Delhi, Aug 7  The Serum Institute of India would introduce candidate vaccines from AstraZeneca and Novavax for COVID-19 at less than Rs 250 per dose in India. The Pune-based institute would offer up to 100 million doses at a

Read Full Article
SII to produce 100M doses of Covid vax for India & LMICs

SII to produce 100M doses of Covid vax for India & LMICs

🕔16:46, 7.Aug 2020

New Delhi, Aug 7  Serum Institute of India (SII), the worlds largest vaccine manufacturer by volume, has entered into a new landmark partnership with Gavi, The Vaccine Alliance and the Bill & Melinda Gates Foundation, to accelerate the manufacture and

Read Full Article
SII to conduct trials of Covishield vaccine

SII to conduct trials of Covishield vaccine

🕔07:13, 22.Jul 2020

New Delhi, July 22  The Serum Institute of India (SII) will launch the first Covid-19 vaccine called ‘Covishield’ and commence its trials soon in India. SII released a representative image of the vial of Covishield which is the vaccine developed

Read Full Article
SII to apply for Oxford vaccine trials in India in a week

SII to apply for Oxford vaccine trials in India in a week

🕔07:32, 21.Jul 2020

New Delhi, July 21  The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of the AstraZeneca-Oxford Covid vaccine. Commenting on the AstraZeneca-Oxford vaccine’s results, Adar Poonawalla, CEO, Serum Institute of India, said,

Read Full Article
Serum Institute CEO says vaccine development is like rollercoaster

Serum Institute CEO says vaccine development is like rollercoaster

🕔07:43, 22.May 2020

New Delhi, May 22  Adar Poonawalla, CEO, Serum Institute of India (SII), said on Thursday that developing a vaccine is like a rollercoaster ride with ups and downs. “Developing a vaccine is like riding a rollercoaster; there are plenty of

Read Full Article